<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Current Pediatric Reviews</journal-id><journal-title-group><journal-title xml:lang="en">Current Pediatric Reviews</journal-title><trans-title-group xml:lang="ru"><trans-title>Current Pediatric Reviews</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1573-3963</issn><issn publication-format="electronic">1875-6336</issn><publisher><publisher-name xml:lang="en">Bentham Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">645688</article-id><article-id pub-id-type="doi">10.2174/1573396319666221027123723</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>Medicine</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Chronic Non-bacterial Osteomyelitis (CNO) In Childhood: A Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Price-Kuehne</surname><given-names>Fiona</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Armon</surname><given-names>Kate</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution>Department of Paediatrics, Cambridge University Hospitals NHS Foundation Trust</institution></aff><pub-date date-type="pub" iso-8601-date="2024-04-01" publication-format="electronic"><day>01</day><month>04</month><year>2024</year></pub-date><volume>20</volume><issue>4</issue><issue-title xml:lang="ru"/><fpage>405</fpage><lpage>411</lpage><history><date date-type="received" iso-8601-date="2025-01-11"><day>11</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Bentham Science Publishers</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Bentham Science Publishers</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://journals.eco-vector.com/1573-3963/article/view/645688">https://journals.eco-vector.com/1573-3963/article/view/645688</self-uri><abstract xml:lang="en"><p id="idm46466589694544">Chronic non-bacterial osteomyelitis (CNO) is an autoinflammatory bone disorder mostly affecting children and adolescents. Although it is considered a rare disease, CNO is likely to be the single most common autoinflammatory bone disease in childhood, underdiagnosed and underreported due to a lack of awareness of the condition in both medics and patients and the absence of validated diagnostic criteria. The exact underlying pathogenesis of CNO remains unknown, making targeted treatment difficult. This issue is exacerbated by the lack of any randomised control trials, meaning that treatment strategies are based solely on retrospective reviews and case series.</p><p id="idm46466589698544">:This review summarises the current concepts in pathophysiology, the clinical features that help differentiate important differential diagnoses, and an approach to investigating and managing children with CNO. Ultimately, the timely and thorough investigation of children and young people with CNO is vitally important to exclude important mimics and initiate appropriate management that can prevent the complications of persistent inflammatory bone disease.</p></abstract><kwd-group xml:lang="en"><kwd>Autoinflammatory bone disorder</kwd><kwd>chronic nonbacterial osteomyelitis</kwd><kwd>chronic recurrent multifocal osteomyelitis</kwd><kwd>clinical features</kwd><kwd>current concepts in pathophysiology</kwd><kwd>investigation and management.</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Schnabel A, Range U, Hahn G, Berner R, Hedrich CM. Treatment response and longterm outcomes in children with chronic nonbacterial osteomyelitis. J Rheumatol 2017; 44(7): 1058-65. doi: 10.3899/jrheum.161255 PMID: 28461645</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ben-Chetrit E, Gattorno M, Gul A, et al. Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study. Ann Rheum Dis 2018; 77(11): 1558-65. doi: 10.1136/annrheumdis-2017-212515 PMID: 30100561</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med 2006; 3(8): e297. doi: 10.1371/journal.pmed.0030297 PMID: 16942393</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Roderick MR, Shah R, Rogers V, Finn A, Ramanan AV. Chronic recurrent multifocal osteomyelitis (CRMO)  advancing the diagnosis. Pediatr Rheumatol Online J 2016; 14(1): 47. doi: 10.1186/s12969-016-0109-1 PMID: 27576444</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Girshick H. Chronic nonbacterial osteomyelitis/Chronic recurrent multifocal osteomyelitis. In: Orphanet Encyclopedia. 2013.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Hofmann SR, Kapplusch F, Girschick HJ, et al. Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment. Curr Osteoporos Rep 2017; 15(6): 542-54. doi: 10.1007/s11914-017-0405-9 PMID: 29080202</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Suo C, Chia D, Toms A, Sanghrajka A, et al. OA33 Incidence of chronic recurrent multifocal osteomyelitis in the UK and Republic of Ireland: initial results from 13 months of surveillance study. Rheumatol Adv Pract 2022; 6 doi: 10.1093/rap/rkac066.033</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Jansson AF, Grote V. Nonbacterial osteitis in children: data of a German Incidence Surveillance Study. Acta Paediatr 2011; 100(8): 1150-7. doi: 10.1111/j.1651-2227.2011.02205.x PMID: 21352353</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Zhao M, Wu D, Yu K, Shen M. Clinical and genetic features of chinese adult patients with chronic non-bacterial osteomyelitis: a single center report. Front Immunol 2022; 13: 860646. doi: 10.3389/fimmu.2022.860646 PMID: 35422809</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Hofmann SR, Schnabel A, Rösen-Wolff A, Morbach H, Girschick HJ, Hedrich CM. Chronic nonbacterial osteomyelitis: Pathophysiological concepts and current treatment strategies. J Rheumatol 2016; 43(11): 1956-64. doi: 10.3899/jrheum.160256 PMID: 27585682</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Broz P, Dixit VM. Inflammasomes: Mechanism of assembly, regulation and signalling. Nat Rev Immunol 2016; 16(7): 407-20. doi: 10.1038/nri.2016.58 PMID: 27291964</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Brandt D, Sohr E, Pablik J, et al. CD14+ monocytes contribute to inflammation in chronic nonbacterial osteomyelitis (CNO) through in-creased NLRP3 inflammasome expression. Clin Immunol 2018; 196: 77-84. doi: 10.1016/j.clim.2018.04.011 PMID: 29723617</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: An overview of mechanisms of activation and regulation. Int J Mol Sci 2019; 20(13): 3328. doi: 10.3390/ijms20133328 PMID: 31284572</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Hofmann SR, Kubasch AS, Ioannidis C, et al. Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1β expression and release. Clin Immunol 2015; 161(2): 300-7. doi: 10.1016/j.clim.2015.09.013 PMID: 26404542</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Hentunen TA, Choi SJ, Boyce BF, et al. A murine model of inflammatory bone disease. Bone 2000; 26(2): 183-8. doi: 10.1016/S8756-3282(99)00247-1 PMID: 10678414</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Chitu V, Ferguson PJ, de Bruijn R, et al. Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice. Blood 2009; 114(12): 2497-505. doi: 10.1182/blood-2009-02-204925 PMID: 19608749</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Chitu V, Nacu V, Charles JF, et al. PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts. Blood 2012; 120(15): 3126-35. doi: 10.1182/blood-2012-04-425595 PMID: 22923495</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Abe K, Fuchs H, Lisse T, Hans W, de Angelis MH. New ENU-induced semidominant mutation, Ali18, causes inflammatory arthritis, der-matitis, and osteoporosis in the mouse. Mamm Genome 2006; 17(9): 915-26. doi: 10.1007/s00335-006-0014-x PMID: 16964445</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Abe K, Cox A, Takamatsu N, et al. Gain-of-function mutations in a member of the Src family kinases cause autoinflammatory bone dis-ease in mice and humans. Proc Natl Acad Sci USA 2019; 116(24): 11872-7. doi: 10.1073/pnas.1819825116 PMID: 31138708</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Jansson A, Renner ED, Ramser J, et al. Classification of non-bacterial osteitis: Retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 2007; 46(1): 154-60. doi: 10.1093/rheumatology/kel190 PMID: 16782988</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Lukens JR, Gurung P, Vogel P, et al. Dietary modulation of the microbiome affects autoinflammatory disease. Nature 2014; 516(7530): 246-9. doi: 10.1038/nature13788 PMID: 25274309</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Kaut S, van den Wyngaert I, Christiaens D, Wouters C, Noppe N, Herregods N, et al. Chronic nonbacterial osteomyelitis in children: a multicentre Belgian cohort of 30 children. Pediatric Rheumatology 2022; 20(1) doi: 10.1186/s12969-022-00698-3</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>OLeary D, Killeen O, Wilson A. Chronic nonbacterial osteomyelitis is associated with HLA-B*27. Arthritis Rheumatol 2020; 72(10): 0083.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Taddio A, Ferrara G, Insalaco A, et al. Dealing with Chronic Non-Bacterial Osteomyelitis: a practical approach. Pediatr Rheumatol Online J 2017; 15(1): 87. doi: 10.1186/s12969-017-0216-7 PMID: 29287595</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Ferguson PJ, Chen S, Tayeh MK, et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). Journal of Medical Genetics 2005; 42(7): 551 LP-7.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Aksentijevich I, Masters SL, Ferguson PJ, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 2009; 360(23): 2426-37. doi: 10.1056/NEJMoa0807865 PMID: 19494218</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Wise CA, Gillum JD, Seidman CE, et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 2002; 11(8): 961-9. doi: 10.1093/hmg/11.8.961 PMID: 11971877</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Yeon HB, Lindor NM, Seidman JG, Seidman CE. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet 2000; 66(4): 1443-8. doi: 10.1086/302866 PMID: 10729114</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Russo RAG, Brogan PA. Monogenic autoinflammatory diseases. Rheumatology (Oxford) 2014; 53(11): 1927-39. doi: 10.1093/rheumatology/keu170 PMID: 24831056</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Morice A, Joly A, Ricquebourg M, et al. Cherubism as a systemic skeletal disease: evidence from an aggressive case. BMC Musculoskelet Disord 2020; 21(1): 564. doi: 10.1186/s12891-020-03580-z PMID: 32825821</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Skrabl-Baumgartner A, Singer P, Greimel T, Gorkiewicz G, Hermann J. Chronic non-bacterial osteomyelitis: a comparative study between children and adults. Pediatr Rheumatol Online J 2019; 17(1): 49. doi: 10.1186/s12969-019-0353-2 PMID: 31337412</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 2016; 12(4): 233-46. doi: 10.1038/nrendo.2016.14 PMID: 26893260</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Girschick HJ, Mornet E, Beer M, Warmuth-Metz M, Schneider P. Chronic multifocal non-bacterial osteomyelitis in hypophosphatasia mimicking malignancy. BMC Pediatr 2007; 7(1): 3. doi: 10.1186/1471-2431-7-3 PMID: 17241478</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Giedion A, Holthusen W, Masel LF, Vischer D. Subacute and chronic "symmetrical" osteomyelitis. Ann Radiol (Paris) 1972; 15(3): 329-42. PMID: 4403064</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Zhao Y, Wu EY, Oliver MS, et al. Consensus treatment plans for chronic nonbacterial osteomyelitis refractory to nonsteroidal anti-inflammatory drugs and/or with active spinal lesions. Arthritis Care Res (Hoboken) 2018; 70(8): 1228-37. doi: 10.1002/acr.23462 PMID: 29112802</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Andreasen CM, Jurik AG, Deleuran BW, et al. Pamidronate in chronic non-bacterial osteomyelitis: a randomized, double-blinded, place-bo-controlled pilot trial. Scand J Rheumatol 2020; 49(4): 312-22. doi: 10.1080/03009742.2020.1724324 PMID: 32484386</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Bhat CS, Roderick M, Sen ES, Finn A, Ramanan AV. Efficacy of pamidronate in children with chronic non-bacterial osteitis using whole body MRI as a marker of disease activity. Pediatr Rheumatol Online J 2019; 17(1): 35. doi: 10.1186/s12969-019-0340-7 PMID: 31272461</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Ramanan AV, Hampson LV, Lythgoe H, et al. Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO. PLoS One 2019; 14(6): e0215739. doi: 10.1371/journal.pone.0215739 PMID: 31166977</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Ramautar AIE, Andela CD, Hamdy NAT, Winter EM, Appelman-Dijkstra NM. Determinants of Quality of Life in Adult Patients with Chronic Non-Bacterial Osteomyelitis (CNO) of the Sternocostoclavicular Region (SCCH): A Dutch Single Center Study. J Clin Med 2022; 11(7): 1852. doi: 10.3390/jcm11071852 PMID: 35407460</mixed-citation></ref></ref-list></back></article>
